Pharmacy benefit management

PBIRx Launches “PBIRx Success Stories” Video Series Featuring Client Case Study Testimonials

Retrieved on: 
Tuesday, March 12, 2024
Insurance, Pharmaceutical, Human Resources, Health, Consulting, Accounting, Professional Services, Health Insurance, Consultant, Pharmacy benefit management, Taft–Hartley Act, International Brotherhood of Teamsters, Partnership, Pharmacy, Multimedia, Hand, Fire, PBM

PBIRx , Inc., a leading pharmacy benefit auditing and consulting firm, is excited to announce the launch of its new video series, PBIRx Success Stories .

Key Points: 
  • PBIRx , Inc., a leading pharmacy benefit auditing and consulting firm, is excited to announce the launch of its new video series, PBIRx Success Stories .
  • These client testimonial videos highlight the successful partnerships between PBIRx and its valued client partners.
  • View the full release here: https://www.businesswire.com/news/home/20240312717007/en/
    The first two videos in the PBIRx Success Stories series spotlight the successful partnership of PBIRx and two Taft-Hartley groups, featuring Tim Morrin, Fund Administrator of Automatic Sprinkler Local 281, U.A.
  • “That’s important to our members and their families today.”
    To view the "PBIRx Success Stories" video series, visit PBIRx.com .

Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, February 27, 2024
Janus, Acquisition, Week, Psoriasis, GTN, Research, Health Canada, Investment, Inflammation, FDA, Marketing, Atopic dermatitis, Food, Dermatitis, Growth, Shanda, Patent, JAK1, PDUFA, Pharmacy benefit management, PDE4, Alopecia areata, Food and Drug Administration, Webcast, Half-life, Disease, SLR, Itch, NDA, Prescription, Scalp, Pharmaceutical industry

The Company saw significant GTN improvement in the fourth quarter compared to the GTN in the third quarter, and anticipates further GTN improvement in 2024.

Key Points: 
  • The Company saw significant GTN improvement in the fourth quarter compared to the GTN in the third quarter, and anticipates further GTN improvement in 2024.
  • Total revenues for the quarter ended December 31, 2023 were $13.5 million compared to $3.0 million for the corresponding period in 2022.
  • Net cash used in operating activities was $56.2 during the fourth quarter and $247.1 million during the full year 2023.
  • Arcutis management will host a conference call and webcast today at 8:30 am ET to discuss the financial results for the quarter and year and provide a business update.

Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

Retrieved on: 
Tuesday, February 6, 2024
FDA, Health, Diabetes, Other Health, General Health, Pharmaceutical, T2D, Better, Food and Drug Administration, Patient, Food, Pharmacy benefit management, Therapy, Negotiation, Type 2 diabetes, Purchasing, System, PBM, Pharmaceutical industry

Better Therapeutics Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced that it has entered into a rebate agreement with one of the nation’s leading Pharmacy Benefit Managers (PBMs) negotiating on behalf of over 70 million lives in the US.

Key Points: 
  • Better Therapeutics Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced that it has entered into a rebate agreement with one of the nation’s leading Pharmacy Benefit Managers (PBMs) negotiating on behalf of over 70 million lives in the US.
  • The rebate agreement, effective January 1, 2024, applies to the PBM’s commercial book of business and provides plan participants of the PBM the ability to add AspyreRx™ to their formularies with rebate eligibility.
  • Better Therapeutics launched AspyreRx in October 2023, after receiving U.S. Food and Drug Administration (FDA) authorization in July 2023 as the first prescription-only digital therapeutic to treat adults with type 2 diabetes (T2D).
  • “This rebate agreement opens up an important pathway for access to treatment for millions of patients with type 2 diabetes," said Frank Karbe , President and CEO at Better Therapeutics.

Healthcare BPO Market size to grow by USD 12.90 billion from 2022 to 2027, Growth Driven by the presence of skilled professionals - Technavio

Retrieved on: 
Tuesday, January 9, 2024
Blockchain, EHR, Geography, Revenue cycle management, Clinical coder, Virtual assistant, Trust, ISO 9001:2015, Research, Population Health Management, Health information management, HIM, Quality control, Strategic planning, Analysis, Health, Certification, Remote patient monitoring, Clinical data management, USD, Insurance, BPO, Pharmacy benefit management, Accounting, Human, Electronic health record, ISO, Growth, PBM, Semiconductor

The potential growth difference for the healthcare BPO market between 2023 and 2027 is USD 12.90 billion.

Key Points: 
  • The potential growth difference for the healthcare BPO market between 2023 and 2027 is USD 12.90 billion.
  • Buy the full report here
    What are the main growth drivers in the Healthcare Business Process Outsourcing (BPO) Market?
  • An essential driver boosting the Healthcare Business Process Outsourcing (BPO) Market growth is the abundance of adept professionals.
  • Data breaches are one of the significant challenges impeding the growth of the Healthcare Business Process Outsourcing (BPO) Market.

AIG Appoints Roshan Navagamuwa as Executive Vice President and Chief Information Officer

Retrieved on: 
Wednesday, November 15, 2023
Professional Services, Insurance, Finance, American International Group, NYSE, Engineering, CVS Health, Multimedia, International Marxist Group, CIO, AIG, EVP, COVID-19, Senior advisor, Lead, Pharmacy benefit management, Health, Aon Hewitt, Management

American International Group, Inc. (NYSE: AIG) today announced that Roshan Navagamuwa will be joining AIG in December and has been named EVP and Chief Information Officer, effective January 1, 2024.

Key Points: 
  • American International Group, Inc. (NYSE: AIG) today announced that Roshan Navagamuwa will be joining AIG in December and has been named EVP and Chief Information Officer, effective January 1, 2024.
  • Mr. Navagamuwa will report to Peter Zaffino, AIG Chairman & Chief Executive Officer, and serve on AIG’s Executive Leadership Team.
  • Mr. Zaffino said: “Roshan is an accomplished technology executive with an impressive track record of innovating software development and managing through complex organizational change.
  • I look forward to working with Peter and the collaborative world-class team he has assembled to employ technology that enables AIG’s innovation, disciplined execution and operational excellence.”
    Mr. Navagamuwa joins AIG from CVS Health (NYSE: CVS), where he was Executive Vice President and Chief Information Officer.

APCI and Transparency-Rx Unite in Congressional Advocacy for Critical PBM Reforms

Retrieved on: 
Monday, November 13, 2023
Medicare Part D, Patient, APCI, Pharmacy benefit management, Medicare, Health care, Congress, PBM, Legislation, Pharmacy, Pharmaceutical industry, Cryptocurrency

BESSEMER, Ala., Nov. 13, 2023 /PRNewswire/ -- American Pharmacy Cooperative, Inc. (APCI) and Transparency-Rx, a not-for-profit coalition led by transparent pharmacy benefit managers (PBMs), are proud to announce their joint efforts in advocating for crucial PBM reforms during bipartisan and bicameral meetings with Congress November 13 and 14. The strategic collaboration aims to address essential issues within the pharmaceutical industry to bolster greater accountability and affordability across the healthcare system.

Key Points: 
  • A recent report from Nephron Research finds that major PBM compensation from fees tied to drug prices doubled between 2018-2022 alone.
  • "APCI and Transparency-Rx are committed to working collaboratively with Congress to address pressing issues within the PBM landscape," said APCI General Counsel and Director of Healthcare Policy Greg Reybold.
  • "Transparency-Rx and APCI are going to Capitol Hill with a simple message: the time for talk about PBM reform is over.
  • Congress must act immediately to enact legislation that bolsters trust and affordability in the PBM market."

Axxess and OnePoint Patient Care Announce Product Integration for Pharmacy Benefit Management Services

Retrieved on: 
Monday, October 23, 2023
PBM, Interoperability, Pharmacy benefit management, Patient, Pharmacy, CMS, Software, Health care, Hospital, Nursing, Axxess

DALLAS, Oct. 23, 2023 /PRNewswire/ -- Axxess and OnePoint Patient Care announced the integration of Axxess Hospice and OnePoint Patient Care's Pharmacy Benefit Management platform. This integration will help alleviate administrative burdens, increase nurse satisfaction, improve retention rates and provide better patient outcomes.

Key Points: 
  • DALLAS, Oct. 23, 2023 /PRNewswire/ -- Axxess and OnePoint Patient Care announced the integration of Axxess Hospice and OnePoint Patient Care's Pharmacy Benefit Management platform.
  • The integration enables hospices to manage pharmacy patient updates, medication updates and CMS medication data.
  • Axxess clients can also use OnePoint's full continuum of pharmacy services, enabling them to select any combination of pharmacy services without changing providers.
  • "We are thrilled to partner with Axxess to provide their users with the best-in-class PBM services," said Jeff Hohl, CEO at OnePoint Patient Care.

The Future of Pharmacy Benefits: Xevant's Latest eBook Unveils “The Top 4 PBM Trends (And What to Expect Next)”

Retrieved on: 
Monday, October 16, 2023
Health, Knowledge, PBM, Organization, Pharmacy benefit management, Newman, Pharmacy, Ebook, Patient, Publishing, Health care, LEHI

Xevant's eBook offers a proactive approach, arming readers with the knowledge to adapt to positive and negative shifts in the industry.

Key Points: 
  • Xevant's eBook offers a proactive approach, arming readers with the knowledge to adapt to positive and negative shifts in the industry.
  • The eBook explores four pivotal trends shaping the future of Pharmacy Benefit Management:
    The increasing competition from biosimilars continues to reshape the specialty market.
  • The eBook analyzes the implications for patients and payers, providing a deep understanding of this transformative trend.
  • "The Top 4 PBM Trends (And What to Expect Next)" is available for download on the Xevant website here .

AHF & Senator Cantwell Hammer PBM Abuse

Retrieved on: 
Friday, October 13, 2023
Advocacy Group Opinion, Elections, Campaigns, LGBTQ+, Public Policy, Government, Healthcare Reform, AIDS, Health, Consumer, Pharmaceutical, Congress, Cathleen, FTC, Multimedia, PBM, AIDS Healthcare Foundation, AHF, Pharmacy benefit management, AARP, Pharmacist, System, Conditional sentence, AP, Risk management, Patient, Senate, Pharmaceutical industry, Pharmacy

Senator Maria Cantwell (D-WA) for hosting a press conference in Washington State today with a coalition of health care providers and pharmacists on Senate Bill 4293, a PBM reform bill the senator introduced last year alongside U.S.

Key Points: 
  • Senator Maria Cantwell (D-WA) for hosting a press conference in Washington State today with a coalition of health care providers and pharmacists on Senate Bill 4293, a PBM reform bill the senator introduced last year alongside U.S.
  • Senator Chuck Grassley (R-IA) and is carefully shepherding through Congress.
  • Sen. Cantwell introduced Senate Bill 4293, the Pharmacy Benefit Manager Transparency Act of 2022, last year alongside U.S.
  • To learn more about AHF, visit us online at AIDShealth.org , find us on Facebook , follow us on Instagram , Twitter , and TikTok , and subscribe to our AHFter Hours podcast.

Elixir Achieves 20 Consecutive Years of URAC PBM Accreditation

Retrieved on: 
Wednesday, October 11, 2023
General Health, Health, Pharmaceutical, Practice Management, Health Insurance, ACHC, Partnership, National Committee for Quality Assurance, NABP, National Committee, Quality assurance, National Association of Boards of Pharmacy, Risk management, PBM, Accreditation, Safety, Pharmacy benefit management, URAC, National Association, Quality, Accreditation Commission for Health Care, NCQA, Hospital, Pharmaceutical industry, Audit, Nursing, Pharmacy, MD, Elixir

Elixir, a leading pharmacy benefit manager, announced that it has received re-accreditation for Pharmacy Benefit Management (PBM) from URAC.

Key Points: 
  • Elixir, a leading pharmacy benefit manager, announced that it has received re-accreditation for Pharmacy Benefit Management (PBM) from URAC.
  • This achievement is earned by the best and Elixir has held this accreditation since 2007.
  • As the only PBM accreditor in the country, the URAC accreditation is a mark of distinction that demonstrates Elixir’s accountability and commitment to quality.
  • URAC accreditation reflects an organization’s commitment to operating at the high standards in the industry,” said URAC President and CEO, Shawn Griffin, MD.